Léri–Weill dyschondrosteosis

Léri–Weill dyschondrosteosis
	Autosomal dominant - en.svg
	Léri–Weill dyschondrosteosis is inherited in an autosomal dominant manner ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;

Léri–Weill dyschondrosteosis or LWD is a rare pseudoautosomal dominant genetic disorder which results in dwarfism with short forearms and legs (mesomelic dwarfism) and a bayonet-like deformity of the forearms (Madelung's deformity).^[1]

Causes[edit]

It is caused by mutations in the SHOX gene found in the pseudoautosomal region PAR1 of the X and Y chromosomes, at band Xp22.33 or Yp11.32.^[2]

SHOX gene deletions have been identified as the major cause of Leri–Weill syndrome.^[3]

Leri–Weill dyschondrosteosis is characterized by mesomelic short stature, with bowing of the radius more so than the ulna in the forearms and bowing of the tibia while sparing the fibula.

Diagnosis[edit]

Diagnosis is made following genetic blood testing.

Treatment[edit]

History[edit]

LWD was first described in 1929 by André Léri and Jean A. Weill.^[4]^[5]

References[edit]

↑ "A Novel Class of Pseudoautosomal Region 1 Deletions Downstream of SHOX Is Associated with Léri–Weill Dyschondrosteosis".Am. J. Hum. Genet..October 2005;77(4)
533–44.doi:10.1086/449313.PMID:16175500.PMC:1275603.
↑ "Identification and characterization of different SHOX gene deletions in patients with Leri–Weill dyschondrosteosys by MLPA assay".J. Hum. Genet..2007;52(1)
21–7.doi:10.1007/s10038-006-0074-5.PMID:17091221.
↑ "Identification and characterization of cryptic SHOX intragenic deletions in three Japanese patients with Léri–Weill dyschondrosteosis".J. Hum. Genet..2008;53(5)
454–9.doi:10.1007/s10038-008-0269-z.PMID:18322641.
↑ synd/1662 at Who Named It?
↑ "Une affection congénitale et symétrique du développement osseux. La dyschondrostéose".Bulletins et memoires de la Société medicale des hôpitaux de Paris.1929;53
1491–1494.

External links[edit]

Léri–Weill dyschondrosteosis[edit]

Navigation-> Medicine - Wellness - Encyclopedia - Health topics - Diseases - Drugs - Gray's Anatomy - W8MD diet - Ketogenic diet - Recipes

Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

[pmid16175500-1] "A Novel Class of Pseudoautosomal Region 1 Deletions Downstream of SHOX Is Associated with Léri–Weill Dyschondrosteosis".Am. J. Hum. Genet..October 2005;77(4)
533–44.doi:10.1086/449313.PMID:16175500.PMC:1275603.

[pmid17091221-2] "Identification and characterization of different SHOX gene deletions in patients with Leri–Weill dyschondrosteosys by MLPA assay".J. Hum. Genet..2007;52(1)
21–7.doi:10.1007/s10038-006-0074-5.PMID:17091221.

[pmid18322641-3] "Identification and characterization of cryptic SHOX intragenic deletions in three Japanese patients with Léri–Weill dyschondrosteosis".J. Hum. Genet..2008;53(5)
454–9.doi:10.1007/s10038-008-0269-z.PMID:18322641.

[4] synd/1662 at Who Named It?

[5] "Une affection congénitale et symétrique du développement osseux. La dyschondrostéose".Bulletins et memoires de la Société medicale des hôpitaux de Paris.1929;53
1491–1494.

[1]

[2]

[3]

[4]

[5]